Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Noble

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|December 20, 2005
Exploiting structural principles to design cyclin-dependent kinase inhibitorsMartin Noble, Paul Barrett, Jane Endicott, et al.
Protein & Cell|January 5, 2011
Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active siteAreej M Abuhammad, Edward D Lowe, Elizabeth Fullam, et al.
Journal of Molecular Biology|October 2, 2007
Molecular cloning, characterisation and ligand-bound structure of an azoreductase from Pseudomonas aeruginosaChan-Ju Wang, Christoph Hagemeier, Nawreen Rahman, et al.
Current Drug Metabolism|August 6, 2008
Arylamine N-acetyltransferases in mycobacteriaEdith Sim, James Sandy, Dimitrios Evangelopoulos, et al.
Structure (London, England : 1993)|February 16, 2008
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor designAnais Merckx, Aude Echalier, Kia Langford, et al.
Nature Structural & Molecular Biology|February 13, 2007
Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interactionSuneale Banerji, Alan J Wright, Martin Noble, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 2, 2004
Developments in the CCP4 molecular-graphics projectLiz Potterton, Stuart McNicholas, Eugene Krissinel, et al.
Journal of Medicinal Chemistry|January 10, 2003
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effectsYvette Mettey, Marie Gompel, Virginie Thomas, et al.
Journal of Medicinal Chemistry|January 11, 2013
Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activitiesHao Shao, Shenhua Shi, Shiliang Huang, et al.
Molecular Cell|March 3, 2004
Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44Peter Teriete, Suneale Banerji, Martin Noble, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|December 20, 2005
Exploiting structural principles to design cyclin-dependent kinase inhibitorsMartin Noble, Paul Barrett, Jane Endicott, et al.
Protein & Cell|January 5, 2011
Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active siteAreej M Abuhammad, Edward D Lowe, Elizabeth Fullam, et al.
Journal of Molecular Biology|October 2, 2007
Molecular cloning, characterisation and ligand-bound structure of an azoreductase from Pseudomonas aeruginosaChan-Ju Wang, Christoph Hagemeier, Nawreen Rahman, et al.
Current Drug Metabolism|August 6, 2008
Arylamine N-acetyltransferases in mycobacteriaEdith Sim, James Sandy, Dimitrios Evangelopoulos, et al.
Structure (London, England : 1993)|February 16, 2008
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor designAnais Merckx, Aude Echalier, Kia Langford, et al.
Nature Structural & Molecular Biology|February 13, 2007
Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interactionSuneale Banerji, Alan J Wright, Martin Noble, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 2, 2004
Developments in the CCP4 molecular-graphics projectLiz Potterton, Stuart McNicholas, Eugene Krissinel, et al.
Journal of Medicinal Chemistry|January 10, 2003
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effectsYvette Mettey, Marie Gompel, Virginie Thomas, et al.
Journal of Medicinal Chemistry|January 11, 2013
Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activitiesHao Shao, Shenhua Shi, Shiliang Huang, et al.
Molecular Cell|March 3, 2004
Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44Peter Teriete, Suneale Banerji, Martin Noble, et al.
Pageof 3